Web Results

Genentech - Wikipedia


Genentech Inc Political Action Committee is a U.S. Federal Political Action Committee (PAC), created ...



Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or ...

Genentech: Contact Us


Contact Us. Our South San Francisco campus, the birthplace of biotechnology.

Genentech, Inc. Company Information | Drugs.com


Genentech, Inc. manufactures, markets and/or distributes more than 36 drugs in the U.S..

Genentech Access


Genentech Access Solutions is your resource for effective access and reimbursement ... The Access Solutions logo is a registered trademark of Genentech, Inc.

Genentech Inc. - The Business Journals


Genentech, Inc. Genentech uses human genetic info to discover, develop, manufacture and commercialize medicines to treat patients with serious medical  ...

Genentech Contact Information and Careers | BioOncology


Corporate headquarters. Genentech USA, Inc. 1 DNA Way South San Francisco, CA 94080-4990. Phone: 1-650-225-1000. Fax: 1-650-225-6000 www.gene.

Genentech, Inc.: Private Company Information - Businessweek


Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients ...

BioSpace - Genentech News, Search Jobs, Events - BioSpace.com


Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a ...

Genentech Foundation


Genentech - A Member of the Roche Group · About Us · Contact Us ... Genentech Foundation. The Genentech ... Terms & Conditions Genentech, Inc. © 2016.

More Info

Genentech: About Us


About Us. Considered the founder of the industry, Genentech, now a member ...

Genentech: South San Francisco


The South San Francisco campus continues to serve as Genentech's corporate ...

Genentech Inc. - Company Profile - BioCentury


…of the Phase III CREAD trial by partner Genentech Inc. this January may have reassured investors of…beta amyloid mAb. Genentech also started a Phase I ...